Skip to main content
SpringerLink
Log in

Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749–57.

    Google Scholar 

  2. Dimopoulos M, Spencer A, Attal M, Prince HM, Harousseau JL, Dmoszynska A, et al. Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med. 2007;357:2123–32.

    Article  CAS  PubMed  Google Scholar 

  3. Weber DM, Chen C, Niesvizky R, Wang M, Belch A, Stadtmauer EA, et al. Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N Engl J Med. 2007;357:2133–42.

    Article  CAS  PubMed  Google Scholar 

  4. Rajkumar SV, Jacobus S, Callander NS, Fonseca R, Vesole DH, Williams ME, et al. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial. Lancet Oncol. 2010;11:29–37.

    Article  CAS  PubMed  Google Scholar 

  5. Iida S, Chou T, Okamoto S, Nagai H, Hatake K, Murakami H, et al. Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma. Int J Hematol. 2010;92:118–26.

    Article  CAS  PubMed  Google Scholar 

  6. Quach H, Ritchie D, Stewart AK, Neeson P, Harrison S, Smyth MJ, et al. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia. 2010;24:22–32.

    Article  CAS  PubMed  Google Scholar 

  7. Ferrajoli A, Lee BN, Schlette EJ, O’Brien SM, Gao H, Wen S, et al. Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia. Blood. 2008;111:5291–7.

    Article  CAS  PubMed  Google Scholar 

  8. Aue G, Njuguna N, Tian X, Soto S, Hughes T, Vire B, et al. Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia. Haematologica. 2009;94:1266–73.

    Article  CAS  PubMed  Google Scholar 

  9. Yang J, Wezeman M, Zhang X, Lin P, Wang M, Qian J, et al. Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis. Cancer Cell. 2007;12:252–65.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan

    Shuji Ozaki, Takeshi Harada, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Ayako Nakano, Kumiko Kagawa, Kyoko Takeuchi, Masahiro Abe & Toshio Matsumoto

  2. Department of Hematology, Tokushima University Hospital, Tokushima, Japan

    Shuji Ozaki, Takeshi Harada, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Ayako Nakano, Kumiko Kagawa, Kyoko Takeuchi & Masahiro Abe

  3. Division of Transfusion Medicine, Tokushima University Hospital, Tokushima, Japan

    Shuji Ozaki & Toshio Matsumoto

Authors
  1. Shuji Ozaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takeshi Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shiro Fujii
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shingen Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hirokazu Miki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ayako Nakano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kumiko Kagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kyoko Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masahiro Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Toshio Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shuji Ozaki.

About this article

Cite this article

Ozaki, S., Harada, T., Fujii, S. et al. Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma. Int J Hematol 93, 257–259 (2011). https://doi.org/10.1007/s12185-011-0775-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-011-0775-1

Keywords

Search

Navigation